Academics questioned on the progress of the UK’s covid-19 vaccination programme
22 February 2021
Science and Technology Committee holds a public evidence session as part of its UK science, research and technology capability and influence in global disease outbreaks inquiry
- Watch Parliament TV: UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
- Inquiry: UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
- Science and Technology Committee
Witnesses
Wednesday 24 February, virtual meeting
At 9.30am
- Professor Anthony Harnden, Deputy Chair, Joint Committee on Vaccination and Immunisation and Professor of Primary Care, University of Oxford
- Professor Wendy Barclay, Head of the Department of Infectious Disease, Imperial College London
At 10.30am
- Madelaine McTernan, Director General, UK Vaccine Taskforce
- Professor Sarah Gilbert, Professor of Vaccinology, University of Oxford
- Dr Philip Dormitzer, Vice President and Chief Scientific Officer of Viral Vaccines, Pfizer
This session will explore the progress of the UK’s covid-19 vaccination programme, including the development of future vaccines and the new variants.
Further information
Image: CCO